Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Lyka Labs Ltd.
Change Company   
BSE Code 500259
ISIN Demat INE933A01014
Book Value 37.39
NSE Code LYKALABS
Dividend Yield % 0.00
Market Cap 3890.21
P/E 73.39
EPS 1.49
Face Value 10  
08-Apr-2025 Lyka Labs gets Indian patent for Pregabalin Gel 8%
08-Apr-2025 Lyka Labs informs about press release
04-Apr-2025 Lyka Labs informs about certificate
05-Mar-2025 Lyka Lab informs about voting results and scrutin...
05-Feb-2025 Lyka Labs informs about integrated filing
04-Feb-2025 Lyka Labs informs about outcome of board meeting
24-Jan-2025 Lyka Labs informs about scheme of amalgamation
30-Dec-2024 Lyka Labs informs about board meeting
26-Oct-2024 Lyka Labs informs about scheme of amalgamation
04-Oct-2024 Lyka Labs informs about board meeting
12-Aug-2024 Lyka Labs informs about newspaper advertisement
18-Jul-2024 Lyka Labs informs about newspaper publication of ...
16-Jul-2024 Lyka Labs informs about press release
26-Jun-2024 Lyka Labs informs about details of loss of certif...
14-May-2024 Lyka Labs informs about change in time of board m...
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.